Understanding Six Types of Vaccine Technologies | Pfizer
Vaccines | Free Full-Text | Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease
Frontiers | Carbohydrate Conjugates in Vaccine Developments
Frontiers | Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases
Conjugate vaccine technology used in meningococcal A vaccine for... | Download Scientific Diagram
T-cell-independent and T-cell-dependent responses to polysaccharide and... | Download Scientific Diagram
Polysaccharide conjugate vaccine: A kind of vaccine with great development potential
Prevenar®- Mechanism of Action | Prevenar 13® | PfizerPro India
A) Non-conjugated polysaccharide vaccines induce only B-cell immunity,... | Download Scientific Diagram
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine | PNAS
Polysaccharides | Free Full-Text | Polysaccharide Vaccines: A Perspective on Non-Typhoidal Salmonella
Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines | Nature Reviews Immunology
Polysaccharides | Free Full-Text | Polysaccharide Vaccines: A Perspective on Non-Typhoidal Salmonella
Frontiers | Safety and Efficacy of Pneumococcal Vaccination in Pediatric Nephrotic Syndrome
Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species - ScienceDirect
Glycoconjugate vaccines: Principles and mechanisms | Science Translational Medicine
A guide to vaccinology: from basic principles to new developments | Nature Reviews Immunology
Preparation of Polysaccharide-Conjugate Vaccines | SpringerLink
Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action | Nature Reviews Chemistry
Enhanced Oral Vaccine Efficacy of Polysaccharide-Coated Calcium Phosphate Nanoparticles | ACS Omega
Conjugate vaccine development services – Celares GmbH
Polysaccharide conjugate vaccine protein carriers as a “neglected valency” – Potential and limitations - ScienceDirect
Neonatal and Infantile Immune Responses to Encapsulated Bacteria and Conjugate Vaccines
